These findings further support our data on B-cell lymphomas and, taken together, suggest that a still unknown mechanism may silence or at least downregulate STING expression in normal and neoplastic EBV-negative B-cells. This evidence concerns the gene STING1 and B-cell non-Hodgkin lymphoma.